Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Glaucine

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Glaucine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
  • none
Identifiers
  • (S)-5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
NIAID ChemDB
CompTox Dashboard(EPA)
ECHA InfoCard100.006.820Edit this at Wikidata
Chemical and physical data
FormulaC21H25NO4
Molar mass355.434 g·mol−1
3D model (JSmol)
  • CN1CCc2cc(c(c-3c2[C@@H]1Cc4c3cc(c(c4)OC)OC)OC)OC
  • InChI=1S/C21H25NO4/c1-22-7-6-12-9-18(25-4)21(26-5)20-14-11-17(24-3)16(23-2)10-13(14)8-15(22)19(12)20/h9-11,15H,6-8H2,1-5H3/t15-/m0/s1 ☒N
  • Key:RUZIUYOSRDWYQF-HNNXBMFYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Glaucine (also known as1,2,9,10-tetramethoxyaporphine,bromcholitin,glauvent,tusidil, andtussiglaucin) is anaporphine alkaloid found in several different plant species in the familyPapaveraceae, such asGlaucium flavum,[1]Glaucium oxylobum, andCorydalis yanhusuo,[2][3] and in other plants such asCroton lechleri in the familyEuphorbiaceae.[4]

It hasbronchodilator,neuroleptic[5] andantiinflammatory effects, acting as aPDE4 inhibitor andcalcium channel blocker,[6] and is used medically as anantitussive in some countries.[7]TLRs plays role in its anti inflammatory effects.[8] Glaucine may produce side effects such assedation,fatigue, and ahallucinogenic effect characterised by colourful visual images,[9][10] and has been detected as anovel psychoactive drug.[11] In a 2019 publication,[12] the isomer (R)-glaucine is reported to be apositive allosteric modulator of the5-HT2A receptor, which is also associated with the hallucinogenic effects of substances such aspsilocybin andmescaline.

Chemistry

[edit]

Stereoisomerism

[edit]

It was believed that only the (S)-form of glaucine occurs in nature until (R)-glaucine was found infire poppy (Papaver californicum).[13]

Glaucine
(2 stereoisomers)
(S)-Glaucine
(S)-configuration
(R)-Glaucine
(R)-configuration

Mechanism of action

[edit]

Glaucine binds to thebenzothiazepine site onL-type Ca2+-channels, thereby blocking calcium ion channels insmooth muscle like the humanbronchus. Glaucine has no effect on intracellular calcium stores, but rather, does not allow the entry of Ca2+ after intracellular stores have been depleted.[6] Ca2+ influx is a vital component in the process of muscular contraction, and the blocking of this influx therefore reduces the ability of the muscle to contract.[14] In this way, glaucine can prevent smooth muscle from contracting, allowing it to relax.

Glaucine has also been demonstrated to be adopamine receptorantagonist, favoring D1 and D1-like receptors.[11][15] It is also anon-competitive selective inhibitor ofPDE4 in human bronchial tissue andgranulocytes. PDE4 is anisoenzyme that hydrolyzescyclic AMP to regulate human bronchial tone (along withPDE3). Yet as aPDE4 inhibitor, glaucine possesses very lowpotency.[6]

Glaucine has also recently[12] been found to have an effect on the neuronal 5-HT2A receptors, which are responsible for the hallucinogenic effects of classicalpsychedelics. It also inhibits MAO enzymes.[16] Its enantiomers effect are same for adrenergic receptor yet different for 5-HT receptor. Both (R)-glaucine and (S)-glaucine antagonizeα1 receptor, but (S)-glaucine is partial agonist of5-HT2 subtypes whereas (R)-glaucine is apositive allosteric modulator of 5-HT2.[17]

Uses

[edit]

Medical

[edit]

It is currently used as anantitussive agent inIceland, as well asRomania,Bulgaria,Russia and other eastern European countries.[6][11] Bulgarian pharmaceutical company Sopharma sells glaucine in tablet form, where a single dose contains 40 mg and thehalf-life is indicated to be 6–8 hours. When ingestedorally has been shown to increaseairway conductance in humans, and has been investigated as a treatment forasthma.[6]

Glaucine has been reported to reduce blood pressure, heart rate and possess anticonvulsant and antinoiciceptive effect in animals.[18][19]

Recreational

[edit]

Reports of recreational use of glaucine have recently been published, and effects include dissociative-type symptoms; feeling detached and 'in another world', as well as nausea, vomiting and dilated pupils. These reports mirror those about the effects of clinical use, which state dissociative-type symptoms as well as lethargy, fatigue, hallucinations.[10][11] Investigation of side effects in a clinical setting also reports that the hallucinatory effects manifest as bright and colorful visualizations. They also report that patients perceive their environments clearly yet feel detached from it; "the patient sees and understands everything and is oriented well enough, but cannot take a clear and adequate action".[10]

One particular report of recreational use gone awry described the form of distribution as tablets being marketed as a1-benzylpiperazine (BZP)-free "herbal high" which the patient referred to as "head candy".[11]

See also

[edit]

References

[edit]
  1. ^Lapa GB, Sheichenko OP, Serezhechkin AG, Tolkachev ON (August 2004). "HPLC Determination of Glaucine in Yellow Horn Poppy Grass (Glaucium flavum Crantz)".Pharmaceutical Chemistry Journal.38 (1):441–442.doi:10.1023/B:PHAC.0000048907.58847.c6.ISSN 0091-150X.S2CID 44040818.S-(+)-Glaucine (C21H25NO4) is the main alkaloid component in the grass of yellow horn poppy (Glaucium luteum L., syn.Glaucium flavum Crantz) of the family Papaveraceae
  2. ^Xu XH, Yu GD, Wang ZT (May 2004). "[Resource investigation and quality evaluation on wild Corydalis yanhusuo]".Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica.29 (5):399–401.PMID 15706885.
  3. ^Morteza-Semnani K, Amin G, Shidfar MR, Hadizadeh H, Shafiee A (July 2003). "Antifungal activity of the methanolic extract and alkaloids of Glaucium oxylobum".Fitoterapia.74 (5):493–6.doi:10.1016/s0367-326x(03)00113-8.PMID 12837370.
  4. ^Milanowski DJ, Winter RE, Elvin-Lewis MP, Lewis WH (June 2002). "Geographic distribution of three alkaloid chemotypes of Croton lechleri".Journal of Natural Products.65 (6):814–9.Bibcode:2002JNAtP..65..814M.doi:10.1021/np000270v.PMID 12088421.
  5. ^Zetler G (1988). "Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine".Archives Internationales de Pharmacodynamie et de Therapie.296:255–281.PMID 2907279.
  6. ^abcdeCortijo J, Villagrasa V, Pons R, Berto L, Martí-Cabrera M, Martinez-Losa M, et al. (August 1999)."Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes".British Journal of Pharmacology.127 (7):1641–51.doi:10.1038/sj.bjp.0702702.PMC 1566148.PMID 10455321.
  7. ^Rühle KH, Criscuolo D, Dieterich HA, Köhler D, Riedel G (May 1984)."Objective evaluation of dextromethorphan and glaucine as antitussive agents".British Journal of Clinical Pharmacology.17 (5):521–4.doi:10.1111/j.1365-2125.1984.tb02384.x.PMC 1463443.PMID 6375709.
  8. ^Remichkova M, Dimitrova P, Philipov S, Ivanovska N (October 2009)."Toll-like receptor-mediated anti-inflammatory action of glaucine and oxoglaucine"(PDF).Fitoterapia.80 (7):411–4.doi:10.1016/j.fitote.2009.05.016.PMID 19481591.
  9. ^Rovinskiĭ VI (September 1989). "[A case of hallucinogen-like action of glaucine]".Klinicheskaia Meditsina.67 (9):107–8.PMID 2586025.
  10. ^abcRovinskiĭ VI (2006). "[Acute glaucine syndrome in the physician's practice: the clinical picture and potential danger]".Klinicheskaia Meditsina.84 (11):68–70.PMID 17243616.
  11. ^abcdeDargan PI, Button J, Hawkins L, Archer JR, Ovaska H, Lidder S, et al. (May 2008). "Detection of the pharmaceutical agent glaucine as a recreational drug".European Journal of Clinical Pharmacology.64 (5):553–4.doi:10.1007/s00228-007-0451-9.PMID 18204834.S2CID 21348503.
  12. ^abHeng, HL, Chee, CF, Thy, CK, et al. In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5‐HT2 and α1 receptors. Chem Biol Drug Des. 2019; 93: 132– 138.https://doi.org/10.1111/cbdd.13390
  13. ^Catania T, Li Y, Winzer T, Harvey D, Meade F, Caridi A, et al. (June 2022)."A functionally conserved STORR gene fusion in Papaver species that diverged 16.8 million years ago".Nature Communications.13 (1) 3150.Bibcode:2022NatCo..13.3150C.doi:10.1038/s41467-022-30856-w.PMC 9174169.PMID 35672295.
  14. ^Nestler E, Hyman S & Malenka R. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). China: McGraw-Hill Companies.
  15. ^Asencio M, Hurtado-Guzmán C, López JJ, Cassels BK, Protais P, Chagraoui A (June 2005)."Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity".Bioorganic & Medicinal Chemistry.13 (11):3699–704.doi:10.1016/j.bmc.2005.03.022.PMID 15862999.
  16. ^Zhang Y, Wang Q, Liu R, Zhou H, Crommen J, Moaddel R, Jiang Z, Zhang T (May 2019). "Rapid screening and identification of monoamine oxidase-A inhibitors from Corydalis Rhizome using enzyme-immobilized magnetic beads based method".Journal of Chromatography A.1592:1–8.doi:10.1016/j.chroma.2019.01.062.PMID 30712820.S2CID 73448412.
  17. ^Heng HL, Chee CF, Thy CK, Tee JT, Chin SP, Herr DR, Buckle MJ, Paterson IC, Doughty SW, Abd Rahman N, Chung LY (February 2019). "In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT2 and α1 receptors".Chemical Biology & Drug Design.93 (2):132–138.doi:10.1111/cbdd.13390.PMID 30216681.S2CID 52278437.
  18. ^Zetler G (1988). "Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine".Archives Internationales de Pharmacodynamie et de Therapie.296:255–81.PMID 2907279.
  19. ^Orallo F, Fernández Alzueta A, Campos-Toimil M, Calleja JM (April 1995)."Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats".British Journal of Pharmacology.114 (7):1419–27.doi:10.1111/j.1476-5381.1995.tb13364.x.PMC 1510273.PMID 7606346.
Opium components
Alkaloids
Morphine group
(Phenanthrenes. Includesopioids)
Isoquinolines
Protopine group
Tetrahydroprotoberberine group
Aporphine group
Phtalide-isoquinolines
α-Naphthaphenanthridines
Other components
Expectorants
Mucolytics
Cough suppressants
Opium alkaloids,
opioids,
and derivatives
Other
Psychedelics
(5-HT2AR agonists)
  • For a full list of serotonergic psychedelics, see the navboxhere and the listhere instead.
Dissociatives
(NMDARantagonists)
Arylcyclo‐
hexylamines
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChRantagonists)
Cannabinoids
(CB1R agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc.
  •  For a full list of cannabinoids, see the navboxhere and the listhere instead.
κORagonists
GABAARagonists
Inhalants
(mixedMoATooltip mechanism of action)
Others
PDE1
PDE2
PDE3
PDE4
PDE5
PDE7
PDE9
PDE10
PDE11
Non-selective
Unsorted
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Retrieved from "https://en.wikipedia.org/w/index.php?title=Glaucine&oldid=1300780383"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp